CARDIFF UNIVERSITY
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1883-01-01
- Employees
- 6.1K
- Market Cap
- -
- Website
- https://cardiff.ac.uk/
Comparison of Medical Therapies in Marfan Syndrome.
- Conditions
- Marfan Syndrome
- Interventions
- First Posted Date
- 2011-02-14
- Last Posted Date
- 2011-02-14
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 18
- Registration Number
- NCT01295047
- Locations
- 🇬🇧
Wales Heart Research Institute, Cardiff University, Cardiff, United Kingdom
Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery
- Conditions
- Colorectal Cancer
- Interventions
- Drug: LeucovorinDrug: fluorouracilDrug: leucovorin calciumDrug: oxaliplatinProcedure: adjuvant therapyProcedure: neoadjuvant therapyProcedure: therapeutic conventional surgeryRadiation: radiation therapy
- First Posted Date
- 2010-12-20
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 60
- Registration Number
- NCT01263171
- Locations
- 🇬🇧
Walsgrave Hospital, Coventry, England, United Kingdom
🇬🇧Velindre Cancer Center at Velindre Hospital, Cardiff, Wales, United Kingdom
🇬🇧Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.
- Conditions
- Acute Myeloid LeukaemiaHigh Risk Myelodysplastic Syndrome
- Interventions
- First Posted Date
- 2010-11-08
- Last Posted Date
- 2014-06-11
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 113
- Registration Number
- NCT01236144
- Locations
- 🇬🇧
Belfast City Hospital, Belfast, United Kingdom
🇬🇧Birmingham Heartlands Hospital, Birmingham, United Kingdom
🇬🇧St Bartholomew's Hospital, London, United Kingdom
Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2010-09-20
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 111
- Registration Number
- NCT01205711
- Locations
- 🇬🇧
Velindre Cancer Center at Velindre Hospital, Cardiff, Wales, United Kingdom
🇬🇧Leicester Royal Infirmary, Leicester, England, United Kingdom
🇬🇧Centre for Cancer Research and Cell Biology at Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
- Conditions
- Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUreter CancerUrethral Cancer
- Interventions
- First Posted Date
- 2010-08-31
- Last Posted Date
- 2019-05-16
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 82
- Registration Number
- NCT01191892
- Locations
- 🇬🇧
Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom
🇬🇧Royal Bournemouth General Hospital, Bournemouth, United Kingdom
🇬🇧Royal Surrey County Hospital, Surrey, United Kingdom
Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer
- Conditions
- Metastatic Breast Cancer
- Interventions
- Drug: PlaceboDrug: ZD4054
- First Posted Date
- 2010-06-02
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- Cardiff University
- Registration Number
- NCT01134497
- Locations
- 🇬🇧
Wales Cancer Trials Unit, Cardiff, United Kingdom
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
- Conditions
- Bladder CancerUrethral CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
- First Posted Date
- 2010-03-22
- Last Posted Date
- 2018-02-06
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 15
- Registration Number
- NCT01090466
- Locations
- 🇬🇧
Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
Risk Factors for Foot Ulceration in the Chronic Kidney Disease (CKD) Population
- Conditions
- Chronic Kidney Disease
- Interventions
- Other: Foot examination
- First Posted Date
- 2010-03-19
- Last Posted Date
- 2010-03-19
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 200
- Registration Number
- NCT01089829
- Locations
- 🇬🇧
University Hospital of Wales, Cardiff, United Kingdom
Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)
- Conditions
- Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
- First Posted Date
- 2010-03-18
- Last Posted Date
- 2018-10-26
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 63
- Registration Number
- NCT01089088
- Locations
- 🇬🇧
Royal Shrewsbury Hospital, Shrewsbury, Shropshire, United Kingdom
🇬🇧Royal Bournemouth Hospital, Bournemouth, England, United Kingdom
🇬🇧The Royal Marsden Hospitals (Surrey), Sutton, Surrey, United Kingdom
Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test
- Conditions
- HypopituitarismHealthyAdrenal Insufficiency
- Interventions
- First Posted Date
- 2009-02-26
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 165
- Registration Number
- NCT00851942
- Locations
- 🇬🇧
Clinical Research Facility, University Hospital of Wales, Cardiff, South Glamorgan, United Kingdom